CD44-纤维蛋白原结合通过原位纤维蛋白(原)沉积促进急性早幼粒细胞白血病出血
本研究探讨急性早幼粒细胞白血病(APL)出血机制,发现APL原始细胞及NB4细胞膜CD44结合纤维蛋白原,导致纤维蛋白原位沉积和异常分布,白血病细胞形成的凝块通透性低且抗纤溶。CD44还通过P-选择素结合活化血小板而非静息血小板,参与血小板与白血病细胞黏附。APL小鼠模型中CD44敲低缩短出血时间、升高纤维蛋白原水平、血小板数量增加约两倍,CD44表达与出血并发症、伤口愈合及生存时间相关。作者认为CD44可能是预防APL出血并发症的潜在干预靶点。
要点
- APL原始细胞及NB4细胞膜CD44结合纤维蛋白原,导致纤维蛋白原位沉积及异常分布。
- 白血病细胞经CD44与纤维蛋白原相互作用形成的凝块通透性低且抗纤溶。
- CD44通过P-选择素结合活化血小板而非静息血小板,参与血小板与白血病细胞黏附。
核心结论
- CD44可能为预防APL出血并发症的潜在干预靶点。
研究设计与样本
- 实验研究,包括APL细胞系NB4细胞及APL小鼠模型,采用流式细胞术和共聚焦显微镜检测。
主要发现
- APL原始细胞及NB4细胞膜CD44结合纤维蛋白原,导致纤维蛋白原位沉积和异常分布。
- 白血病细胞经CD44与纤维蛋白原相互作用形成的凝块通透性低且抗纤溶。
- CD44通过P-选择素结合活化血小板而非静息血小板,参与血小板与白血病细胞黏附。
- APL细胞包被的纤维蛋白原活化血小板直接增强血小板促凝活性。
- APL小鼠模型中CD44敲低缩短出血时间、升高纤维蛋白原水平,血小板数量增加约两倍。
关键数值与推荐
- APL小鼠模型中CD44敲低后血小板数量增加约两倍。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Early hemorrhagic death is still the main obstacle for the successful treatment of acute promyelocytic leukemia (APL). However, the mechanisms underlying hemostatic perturbations in APL have not been fully elucidated. Here, we report that CD44 on the membrane of APL blasts and NB4 cells ligated bound fibrinogen, resulting in in situ deposition of fibrin and abnormal fibrin distribution. Clots formed by leukemic cells in response to CD44 and fibrinogen interaction exhibited low permeability and resistance to fibrinolysis. Using flow cytometry and confocal microscopy, we found that CD44 was also involved in platelet and leukemic cell adhesion. CD44 bound activated platelets but not resting platelets through interaction with P-selectin. APL cell-coated fibrinogen-activated platelets directly induce enhanced procoagulant activity of platelets. In vivo studies revealed that CD44 knockdown shortened bleeding time, increased the level of fibrinogen, and elevated the number of platelets by approximately twofold in an APL mouse model. Moreover, CD44 expression on leukemic cells in an APL mouse model was not only associated with bleeding complications but was also related to the wound-healing process and the survival time of APL mice. Collectively, our results suggest that CD44 may be a potential intervention target for preventing bleeding complications in APL.
引用
- Wang C, Wang Y, Zuo N, et al. CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition. Blood Adv. 2022. PMID: 35511736. doi:10.1182/bloodadvances.2022006980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。